rs1632744
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs1632744(C;C) |
| Make rs1632744(C;T) |
| Make rs1632744(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 5 |
| Position | 104863359 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1632744 |
| dbSNP (classic) | rs1632744 |
| ClinGen | rs1632744 |
| ebi | rs1632744 |
| HLI | rs1632744 |
| Exac | rs1632744 |
| Gnomad | rs1632744 |
| Varsome | rs1632744 |
| LitVar | rs1632744 |
| Map | rs1632744 |
| PheGenI | rs1632744 |
| Biobank | rs1632744 |
| 1000 genomes | rs1632744 |
| hgdp | rs1632744 |
| ensembl | rs1632744 |
| geneview | rs1632744 |
| scholar | rs1632744 |
| rs1632744 | |
| pharmgkb | rs1632744 |
| gwascentral | rs1632744 |
| openSNP | rs1632744 |
| 23andMe | rs1632744 |
| SNPshot | rs1632744 |
| SNPdbe | rs1632744 |
| MSV3d | rs1632744 |
| GWAS Ctlg | rs1632744 |
| GMAF | 0.4867 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
| GWAS snp | |
|---|---|
| PMID | [PMID 23648065 ]
|
| Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors) |
| Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
| Risk Allele | T |
| P-val | 5E-6 |
| Odds Ratio | 1.39 [0.959-2.007] |
